Close
ACHEMA MIDDLE EAST 2026

The FDA Has Finalized Its Prescription Drug REMS Guidelines

The FDA's Final Guidance on REMS programmes for prescription medications, has just been published. The document is officially titled Format and Content of a...

Drug Inspection Pact Between Switzerland And United States

The US and Switzerland have agreed to a Mutual Recognition Agreement (MRA) on pharmaceutical Good Manufacturing Practices (GMP). The US Food and Drug Administration (FDA)...

Clinical Trials Regulation Implementation Progress Report

The Clinical Trial Information System went live on January 31, 2022, which began the one-year transition period for all clinical trial sponsors. Clinical trial...

5 FDA Rulings To Keep An Eye On In The 2023 First Quarter

The biotechnology sector had a decline in 2022 that went beyond just falling stock prices. Additionally, only 37 new drugs were approved by the...

Drugs To Watch For In 2023 That Could Become Blockbusters

In the 70 pharmaceuticals featured in Clarivate Plc's Drugs to WatchTM 2023 study, comprising potential blockbuster drugs, the bulk were found to be personalised...

Gut Microbiota Is Important In Parkinsons, As Per A Study

Metagenomics, the study of genetic material extracted directly from the stool microbiomes of people with PD and neurologically healthy control participants, was used by...

A Breakthrough Medication For Dystonia Is Being Developed

Thousands of musicians now have hope after substantial progress was made in the search for a dystonia cure by a research team in Korea. 1–3%...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...